• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 SPP1+S100P+、MS4A1-SPP1+S100P+ 细胞亚型是肝内胆管癌的关键亚群。

Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma.

机构信息

Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China; Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.

International Medical Department, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

出版信息

Biochim Biophys Acta Gen Subj. 2023 Sep;1867(9):130420. doi: 10.1016/j.bbagen.2023.130420. Epub 2023 Jul 9.

DOI:10.1016/j.bbagen.2023.130420
PMID:37433400
Abstract

BACKGROUND

In this study, we integrated single-cell RNA sequencing (scRNA-seq) data to investigate cell heterogeneity and utilized MSigDB and CIBERSORTx to explore the pathways of major cell types and the relationships between different cell subtypes. Subsequently, we explored the correlation of cell subtypes with survival and used Gene Set Enrichment Analysis (GSEA) analyses to assess the pathways associated with the infiltration of specific cell subtypes. Finally, multiplex immunohistochemistry in tissue microarray cohort were performed to validate differences in protein level and their correlation with survival.

RESULTS

iCCA presented a unique immune ecosystem, with increased proportions of Epi (epithelial)-SPP1-2, Epi-S100P-1, Epi-DN (double negative for SPP1 and S100P expression)-1, Epi-DN-2, Epi-DP (double positive for SPP1 and S100P expression)-1, Plasma B-3, Plasma B-2, B-HSPA1A-1, B-HSPA1A-2 cells, and decreased proportions of B-MS4A1. High level of Epi-DN-2, Epi-SPP1-1, Epi-SPP1-2, B-MS4A1, and low level of Epi-DB-1, Epi-S100P-1, and Epi-S100P-2 was significantly associated with longer overall survival (OS), and high level of B-MS4A1_Low_Epi-DN-2_Low was associated with the shortest OS. Moreover, the results of MsigDB and GSEA suggest that bile acid metabolism is a crucial process in iCCA. Finally, we found that S100P+, SPP1+, SPP1 + S100P+, and MS4A1-SPP1 + S100P+ were highly expressed, whereas MS4A1 was lowly expressed in iCCA, and patients with high level of S100P+, SPP1 + S100P+, and MS4A1-SPP1 + S100P+ exhibited shorter survival.

CONCLUSIONS

We identified the cell heterogeneity of iCCA, found that iCCA is a unique immune ecosystem with many cell subtypes, and showed that the novel cell subtypes of SPP1 + S100P+ and MS4A1-SPP1 + S100P+ were key subpopulations in iCCA.

摘要

背景

在这项研究中,我们整合了单细胞 RNA 测序 (scRNA-seq) 数据,以研究细胞异质性,并利用 MSigDB 和 CIBERSORTx 来探索主要细胞类型的途径以及不同细胞亚型之间的关系。随后,我们探索了细胞亚型与生存的相关性,并使用基因集富集分析 (GSEA) 分析来评估与特定细胞亚型浸润相关的途径。最后,在组织微阵列队列中进行了多重免疫组织化学验证,以验证蛋白水平的差异及其与生存的相关性。

结果

iCCA 呈现出独特的免疫生态系统,Epi (上皮)-SPP1-2、Epi-S100P-1、Epi-DN (SPP1 和 S100P 表达均为阴性)-1、Epi-DN-2、Epi-DP (SPP1 和 S100P 表达均为阳性)-1、Plasma B-3、Plasma B-2、B-HSPA1A-1、B-HSPA1A-2 细胞的比例增加,而 B-MS4A1 的比例减少。Epi-DN-2、Epi-SPP1-1、Epi-SPP1-2、B-MS4A1 高水平和 Epi-DB-1、Epi-S100P-1、Epi-S100P-2 低水平与总生存期 (OS) 延长显著相关,而 B-MS4A1_Low_Epi-DN-2_Low 高水平与 OS 最短相关。此外,MsigDB 和 GSEA 的结果表明,胆汁酸代谢是 iCCA 中的一个关键过程。最后,我们发现 S100P+、SPP1+、SPP1+S100P+和 MS4A1-SPP1+S100P+在 iCCA 中高表达,而 MS4A1 低表达,高水平的 S100P+、SPP1+S100P+和 MS4A1-SPP1+S100P+患者的生存时间更短。

结论

我们确定了 iCCA 的细胞异质性,发现 iCCA 是一个具有多种细胞亚型的独特免疫生态系统,并表明 SPP1+S100P+和 MS4A1-SPP1+S100P+等新型细胞亚型是 iCCA 的关键亚群。

相似文献

1
Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma.新型 SPP1+S100P+、MS4A1-SPP1+S100P+ 细胞亚型是肝内胆管癌的关键亚群。
Biochim Biophys Acta Gen Subj. 2023 Sep;1867(9):130420. doi: 10.1016/j.bbagen.2023.130420. Epub 2023 Jul 9.
2
Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma.单细胞转录组分析提示肝内胆管癌存在两种分子亚型。
Nat Commun. 2022 Mar 28;13(1):1642. doi: 10.1038/s41467-022-29164-0.
3
An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.免疫组化染色 C 反应蛋白、N-钙黏蛋白和 S100 钙结合蛋白 P 有助于肝内胆管癌分型。
Hum Pathol. 2021 Mar;109:45-52. doi: 10.1016/j.humpath.2020.12.005. Epub 2020 Dec 13.
4
An Immunohistochemical Analysis of Osteopontin and S100 Calcium-binding Protein P is Useful for Subclassifying Large- and Small-duct Type Intrahepatic Cholangiocarcinomas.骨桥蛋白和 S100 钙结合蛋白 P 的免疫组织化学分析有助于对大、小胆管型肝内胆管癌进行亚分类。
Am J Surg Pathol. 2024 Jun 1;48(6):751-760. doi: 10.1097/PAS.0000000000002224. Epub 2024 Apr 8.
5
Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.S100P 过表达在肝内胆管癌中的不同作用:肝门周围型的致癌作用和周围型的侵袭行为。
Am J Surg Pathol. 2011 Apr;35(4):590-8. doi: 10.1097/PAS.0b013e31820ffdf1.
6
Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinoma.小胆管型和大胆管型肝内胆管细胞癌的异质性。
Histopathology. 2024 May;84(6):1061-1067. doi: 10.1111/his.15162. Epub 2024 Feb 26.
7
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing.单细胞 RNA 测序评估 SPP1-CD44 在肝内胆管癌肿瘤微环境中的免疫抑制作用。
J Cancer Res Clin Oncol. 2023 Aug;149(9):5497-5512. doi: 10.1007/s00432-022-04498-w. Epub 2022 Dec 5.
8
Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.全面分析基因组突变特征和肿瘤突变负担对肝内胆管癌预后的影响。
BMC Cancer. 2021 Feb 3;21(1):112. doi: 10.1186/s12885-021-07788-7.
9
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma.多组学分析揭示代谢亚型并确定二酰甘油激酶α(DGKA)作为肝内胆管癌的潜在治疗靶点。
Cancer Commun (Lond). 2024 Feb;44(2):226-250. doi: 10.1002/cac2.12513. Epub 2023 Dec 24.
10
Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities.肝内胆管癌:典型特征、罕见变异及存在争议的相关实体
Hum Pathol. 2023 Feb;132:197-207. doi: 10.1016/j.humpath.2022.06.001. Epub 2022 Jun 11.

引用本文的文献

1
Neoadjuvant PD-1 blockade induces the autophagy of immune cells: a new target for synergistic therapy of recurrent glioblastoma.新辅助PD-1阻断诱导免疫细胞自噬:复发性胶质母细胞瘤协同治疗的新靶点。
Biochem Biophys Rep. 2025 Jun 27;43:102119. doi: 10.1016/j.bbrep.2025.102119. eCollection 2025 Sep.
2
Multiple roles of S100P in pan carcinoma: Biological functions and mechanisms (Review).S100P在泛癌中的多重作用:生物学功能与机制(综述)
Oncol Rep. 2025 Jun;53(6). doi: 10.3892/or.2025.8895. Epub 2025 Apr 11.
3
PLXNB1/SEMA4D signals mediate interactions between malignant epithelial and immune cells to promote colorectal cancer liver metastasis.
PLXNB1/SEMA4D 信号介导恶性上皮细胞和免疫细胞之间的相互作用,促进结直肠癌肝转移。
J Cell Mol Med. 2024 Oct;28(20):e70142. doi: 10.1111/jcmm.70142.
4
Integration of single-cell sequencing and bulk RNA-seq to identify and develop a prognostic signature related to colorectal cancer stem cells.整合单细胞测序和批量 RNA-seq 以鉴定和开发与结直肠肿瘤干细胞相关的预后标志物。
Sci Rep. 2024 May 28;14(1):12270. doi: 10.1038/s41598-024-62913-3.